Driven by gains in banking, IT stocks, Sensex ends 85 points higher
Benchmarks Domestic indices today logged gains for third session in a row even as cues from global equity markets were negative. Sensex at Bombay Stock
Category : Business News
Wholesale price index inflation declines to near 2-year low in June
Wholesale price-based inflation declined for the second consecutive month to its 23-month low of 2.02 per cent in June, helped by a decline in prices
Sensex plunges 174 points, Nifty ends at 11,499
Benchmarks Domestic indices, Sensex and Nifty, today closed with losses amid mixed cues from global equities. Sensex at Bombay Stock Exchange lost 174 points or
Sensex, Nifty fall for third session in a row
Benchmarks Domestic indices, Sensex and Nifty, today fell for third session in row amid selloff in global equities. In afternoon trade Sensex at Bombay Stock
Sensex declines 793 points; Nifty settles at 11,559
Benchmarks Domestic indices today plunged more than two per cent. The Sensex and Nifty, both, tumbled for the second session in a row amid heavy
Aadhaar card can be used in place of PAN for filing IT returns
Secretary, Department of Financial Services, Rajiv Kumar today said, infusion of 70,000 crore rupees in the public sector banks proposed in the budget is aimed
Sensex dives 395 points as panic selling weighs in, Nifty settles at 11,811
At the stock markets, the Sensex at the Bombay Stock Exchange plunged 395 points, or 1 percent, to close at 39,513, on the day of
Eight core sectors grow by 5.1% in May
The eight core sectors in the country have recorded a growth of 5.1 per cent in May on the back of healthy output in steel
Demonetisation had no effect on Indian economy: Finance Minister
Finance Minister Nirmala Sitharaman yesterday said that there was no impact of demonetisation on the Indian economy and the country still continues to be the
Sensex jumps 292 points, pharma and financial stocks lead the rally
Key indices post solid gains after two days of losses, today, and the rupee strengthened slightly against the dollar at the stock markets. The shares of pharma